Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Fulcrum Therapeutics (FULC) vs. Competitors

519 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
FULCFulcrum Therapeutics$3.68$285.35M-3.05-55.98%HoldUnlock the FULC analyst price target with TipRanks PremiumFULCUnlock the FULC top-analyst price target with TipRanks Premium
MNPRMonopar Therapeutics Inc$72.68$481.46M-28.55-11.99%Strong BuyUnlock the MNPR analyst price target with TipRanks PremiumFULC vs MNPRUnlock the MNPR top-analyst price target with TipRanks Premium
ADCTADC Therapeutics$1.41$204.27M-2.77-65.19%Moderate BuyUnlock the ADCT analyst price target with TipRanks PremiumFULC vs ADCTUnlock the ADCT top-analyst price target with TipRanks Premium
GLUEMonte Rosa Therapeutics$9.31$880.99M-5.50-34.25%Strong BuyUnlock the GLUE analyst price target with TipRanks PremiumFULC vs GLUEUnlock the GLUE top-analyst price target with TipRanks Premium
INBXInhibrx Biosciences Inc$87.75$1.33B-10.0919.67%Strong BuyUnlock the INBX analyst price target with TipRanks PremiumFULC vs INBXUnlock the INBX top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
FULCFulcrum Therapeutics3.68-5.11-58.13%
MNPRMonopar Therapeutics Inc72.68-14.33-16.47%
ADCTADC Therapeutics1.41-2.64-65.19%
GLUEMonte Rosa Therapeutics9.31-5.01-34.99%
INBXInhibrx Biosciences Inc87.7513.1317.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts